Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

Culotte stenting for the treatment of unprotected distal LM with compromised Lcx ostium: the difficulty to cross stents cell with balloons

18 May 2021 – From EuroPCR 2021

In this session, analyze culotte stenting in patient with significant distal left main stenosis.

Culotte stenting for the treatment of unprotected distal LM with compromised Lcx ostium: the difficulty to cross stents cell with balloons

EuroPCR 2021 - Innovations in stents & scaffolds

18 May 2021 – From EuroPCR 2021

This session will enable you to find out more about arterial balloon with variable pressures, SPAS (stent positioning assistance systems), thrombectomy with a novel stent retriever in patients with large thrombus burden, and bionanosensored stents.

EuroPCR 2021 - Innovations in stents & scaffolds

EuroPCR 2021 - Innovations in bifurcation lesions

18 May 2021 – From EuroPCR 2021

This session will show you that in two-stent techniques, superior image quality may optimize precise stent placement, and that bifurcation stent for short left main artery can be made in cath lab.

EuroPCR 2021 - Innovations in bifurcation lesions

PCR's Got Talent - Coronary and Other Cardiovascular Interventions

18 May 2021 – From EuroPCR 2021

Thanks to the abstracts gathered in this session, analyze the impact of repeat revascularization on 10-year mortality, study the randomized comparison between radial and femoral large-bore access in complex PCI, appraise the value of absolute flow measurement in patients with CAD, and much more!

PCR's Got Talent - Round 2: Coronary and Other Cardiovascular Interventions

The power of Big Data: can a network meta-analysis reveal the true performance of a DES?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Tullio Palmerini in order to learn about the recently published Network Meta-Analysis on TLF with current DES, to review the role of ultrathin DES in optimising clinical outcomes, and to assess the impact of the results on your daily practice.

The power of Big Data: can a network meta-analysis reveal the true performance of a DES?

FFR-guided PCI optimisation directed by high-definition IVUS

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.

FFR-guided PCI optimisation directed by high-definition IVUS

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

The latest on the prevail drug-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.

The latest on the prevail drug-coated balloon